Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 18.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 18.0 Contact Hours.

To earn an additional 4.0 AMA PRA Category 1 Credits™, attend the CAR T Preconference Workshop.
 


 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 18.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Accreditation/Designation of Credit for Nursing Track (Clinical Pearls for Practice Educational Session and Networking for Advanced Practitioners)

This activity is approved for 1.75 contact hour(s) of continuing education (which includes 1.75 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 19023560. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AbbVie Inc., Acerta Pharma – A member of the AstraZeneca Group, Adaptive Biotechnologies, Celgene Corporation, Daiichi Sankyo, Inc., Gilead Sciences, Inc., Jazz Pharmaceuticals, Inc., NewLink Genetics, Novartis Pharmaceuticals Corporation, Rigel Pharmaceuticals, Inc., Seattle Genetics, Inc., and Takeda Oncology.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2019
Physicians’ Education Resource ®, LLC.
All rights reserved.

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma


Thursday, February 28, 2019 – Sunday, March 3, 2019
Eden Roc Miami

4525 Collins Avenue
Miami Beach, FL, 33140
Phone: 305-531-0000
Hotel Website

 

Overview



Now in its 23rd year, the annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma provides practitioners who manage hematologic malignancies the practical tools to translate emerging data into the best therapy for patients with these tumors, personalize care based upon patient and tumor characteristics, and apply novel management strategies to their practices to improve outcomes for their patients.

Back by popular demand! This 3.5-day meeting will be held from Thursday through mid-afternoon Sunday. As always, agenda topics will focus on methods to apply state-of-the-art strategies to your clinical practice settings. This engaging and highly interactive meeting will provide ample opportunity to interact with internationally renowned experts in the management of leukemias, lymphomas, myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, and benign hematologic malignancies. Our faculty will distill practice-changing evidence and recommend methods to place this information in its proper clinical context so it can be applied to the real-world care scenarios you encounter. In doing so, a focus will be placed on how to proactively mitigate and manage treatment-related toxicities associated with new treatment strategies.

The well-known and highly interactive Medical Crossfire® discussion panels interspersed throughout the meeting will allow attendees to explore some of the most challenging clinical situations in the management of hematologic malignancies, many of which have multiple potential approaches to care.

This dynamic Congress will challenge participants to apply new information they have learned, reflect on new practices they can bring back to their clinics to share with their peers, and ultimately improve patient outcomes in their practice settings.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AbbVie Inc., Acerta Pharma – A member of the AstraZeneca Group, Adaptive Biotechnologies, Celgene Corporation, Daiichi Sankyo, Inc., Gilead Sciences, Inc., Jazz Pharmaceuticals, Inc., NewLink Genetics, Novartis Pharmaceuticals Corporation, Rigel Pharmaceuticals, Inc., Seattle Genetics, Inc., and Takeda Oncology.

Target Audience

This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies may also participate.

Hot Topics for 2019:

  • The expanding role of new immunologic approaches, including CAR T cells and checkpoint inhibitors, in hematologic malignancies
  • The emergence of molecular-based therapies and new cytotoxic formulations in patients with acute leukemias
  • Effective utilization of the increasing therapeutic armamentarium in multiple myeloma
  • New clinical considerations for frontline and subsequent strategies for Hodgkin and non-Hodgkin lymphomas
  • Patient, disease, and drug characteristics will inform sequencing decisions in patients with chronic lymphocytic leukemia
  • New approaches for treatment and duration of therapy among patients with myeloproliferative neoplasms

Co-Chairs

Andre H. Goy, MD, MS
Chairman and Executive Director
Lymphoma Division Chief - John Theurer Cancer Center
Chief Science Officer - RCCA
Lydia Pfund Chair for Lymphoma
Professor of Medicine, Georgetown University
Hackensack, NJ
 
Jorge Cortes, MD
Jane and John Justin Distinguished Chair in Leukemia Research
Chief, CML & AML Sections
Deputy Chair, Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX
 
Sagar Lonial, MD, FACP
Professor, Emory School of Medicine
Chair, Department of Hematology & Medical Oncology
Chief Medical Officer
Winship Cancer Institute of Emory University
Atlanta, GA




Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit






Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
262728293031
Filter By